Incyte Corporation (4INCY.TI)
TLO - TLO Delayed price. Currency in EUR
Add to watchlist
At close: 04:30PM CEST
| Previous close | 52.82 |
| Open | 54.78 |
| Bid | 52.06 x N/A |
| Ask | 53.22 x N/A |
| Day's range | 54.36 - 54.78 |
| 52-week range | 47.41 - 60.92 |
| Volume | |
| Avg. volume | 12 |
| Market cap | N/A |
| Beta (5Y monthly) | 0.67 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 30 July 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireIncyte to Present at Upcoming Investor Conference
WILMINGTON, Del., May 02, 2024--Incyte (Nasdaq:INCY) announced today that it will present at the Bank of America Securities 2024 Health Care Conference on Wednesday, May 15, 2024 at 8:00 a.m. (PDT) in Las Vegas.
Business WireIncyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs
WILMINGTON, Del., April 30, 2024--Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs
Business WireIncyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
WILMINGTON, Del. & SAN DIEGO, April 23, 2024--Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
© 2024 Yahoo. All rights reserved.